Cancer Archives - TimmermanReport.com

Sep

2018

WuXi Eyes A Fresh $1B, California Aims at AbbVie, and MSK’s Industry Ties in the Spotlight

Luke Timmerman

All, Cancer

21 Sep 2018

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

Jul

2018

Nine Observations on Leadership and Teamwork from Mt. Everest

Luke Timmerman

All, Cancer

17 Jul 2018

Most of you have heard by now that I reached the summit of Mt. Everest, the highest mountain in the world, on May 22. Not only was this a dream come true, it was the culmination of my charity fundraising campaign, the Everest Climb to Fight Cancer. It fetched $339,000 for cancer research at the Fred Hutch, a leading center...

Jun

2018

EHA18 Preview: Blood Drugs to Watch in Stockholm

Luke Timmerman

All, Cancer

13 Jun 2018

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

May

2018

Re-Starting a Company, Keeping Hope Alive: Chip Clark on The Long Run

Luke Timmerman

All, Cancer

23 May 2018

Today’s guest on The Long Run is Chip Clark. He’s the CEO of Cambridge, Mass.-based Genocea Biosciences. This vaccine platform company got into a jam last summer. It completed a Phase II trial with its lead therapeutic vaccine for genital herpes. Clark tried to insist the trial was a success and the product had a future. The market disagreed. The...

Apr

2018

Harnessing What Was There All Along. Book Review of ‘A Cure Within’

Kyle Serikawa

All, Cancer

20 Apr 2018

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

Mar

2018

Mt. Everest: It’s Time

Luke Timmerman

All, Cancer

26 Mar 2018

Six months of hard training is in the bank. Tomorrow morning, I will lug a pair of 120-liter gear bags to the airport and get on the plane for Kathmandu. Destination: Mt. Everest, 29,029 feet/8,848 meters. The summit of the highest mountain in the world. No matter what happens, three things are certain: I’ve given it everything I’ve got to prepare...

Mar

2018

TCR2 Therapeutics Grabs $125M to Take TCR Therapies, Sans HLA Screens, To the Clinic

Luke Timmerman

All, Cancer, Venture Capital

21 Mar 2018

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

Mar

2018

Photo Gallery: The Boston Cancer Summit

Luke Timmerman

All, Cancer

12 Mar 2018

What a whirlwind last week was! The Seattle and Boston Cancer Summits were an East-West combo punch on behalf of the Everest Climb to Fight Cancer fundraising campaign for Fred Hutch. These events did the job: Bringing together leading thinkers and doers on both coasts, they both drew sellout, highly engaged crowds. The fundraising tally now stands at $326,000!! The...

Mar

2018

Photo Gallery: The Seattle Cancer Summit

Luke Timmerman

All, Cancer

12 Mar 2018

Mar

2018

What’s Better Than Curing Cancer? Preventing It!

Stewart Lyman

All, Cancer

08 Mar 2018

You don’t have to be an oncologist to know that fighting cancer is tough. Nearly 1.7 million Americans will be diagnosed with cancer this year, and about 600,000 will die from the disease. But here’s some good news: overall U.S. cancer deaths have been in a steep decline for over 25 years. Much of this reduction is tied to a...

Mar

2018

Getting to Precision Medicine for I-O Combinations – It’s Even More Complicated

Leora Schiff

All, Cancer

05 Mar 2018

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

Feb

2018

All-Star Lineup for Boston Cancer Summit, March 7: Novartis, J&J, Third Rock, Atlas

Luke Timmerman

All, Cancer

16 Feb 2018

Timmerman Report is bringing together major East Coast cancer R&D players for an intimate half-day event on March 7: the Boston Cancer Summit. Join an all-star gathering of pharma executives, hot startups, and VCs making things happen in the treatment and diagnosis of cancer. Tickets are sold out. The conference will be at Sanofi Genzyme’s flagship building in the heart of Kendall Square....

Feb

2018

Mingle in Seattle with Genentech, Celgene, OrbiMed, 5AM & More, March 5

Luke Timmerman

All, Cancer

15 Feb 2018

Exclusive Event, Powerhouse Lineup: Seattle Cancer Summit Seattle biotech events don’t get any better than this. Timmerman Report is bringing together major West Coast players for an intimate half-day event on March 5: the Seattle Cancer Summit. Tickets are limited and going fast. And all proceeds go to the Fred Hutchinson Cancer Research Center, as part of my Everest Climb to Fight...

Jan

2018

The Boston Cancer Summit & Seattle Cancer Summit. Two Can’t-Miss Events

Luke Timmerman

All, Cancer, The Edge

29 Jan 2018

Cancer wasn’t that exciting to write about when I started 15 years ago. It is now. Survival rates for several forms of cancer are going in the right direction. Immunotherapy, targeted therapy, new information on genes and proteins that redefine the molecular nature of malignancy? It’s coming together. The science is bursting with creativity, and moving fast. I’m thinking and...

Jan

2018

Leveraging June’s I-O Team at Penn, Tmunity Fetches $100M from Gilead, Parker & Ping An

Luke Timmerman

All, Cancer

23 Jan 2018

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

Jan

2018

Microsoft Makes Nine-Figure Bet on Adaptive’s TCR-Antigen Map; BioNTech Hauls in $270M for 10-Drug Cancer Pipeline

Luke Timmerman

All, Cancer

04 Jan 2018

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

Dec

2017

Walk & Talk With Me on Powell Street at #JPM18

Luke Timmerman

All, Cancer

18 Dec 2017

JPM is right around the corner. You are probably packing your calendar with one-on-one meetings, programmed events, and evening receptions. So am I. But this year, I’m adding a fun new wrinkle. I’d like you to join me. Let’s start with the basics: I need to train for the Everest Climb to Fight Cancer at Fred Hutch. San Francisco has...